Superior vena cava syndrome physical examination

Jump to: navigation, search

Superior Vena Cava Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Superior Vena Cava Syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Superior vena cava syndrome physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Superior vena cava syndrome physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Superior vena cava syndrome physical examination

CDC on Superior vena cava syndrome physical examination

Superior vena cava syndrome physical examination in the news

Blogs on Superior vena cava syndrome physical examination

Directions to Hospitals Treating Superior vena cava syndrome

Risk calculators and risk factors for Superior vena cava syndrome physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Common physical examination findings of superior vena cava syndrome include the pemberton's sign, facial swelling, and jugular venous distension.

Physical Examination

Appearance of the Patient

Vital Signs

  • Low-grade fever
  • Tachypnea
  • Kussmal respirations may be present in advanced SVCS.
  • Asymmetric pulse

Skin

HEENT

Neck

Lungs

  • Asymmetric chest expansion
  • Wheezing may be present

Extremities

  • Edema of the upper extremities

References

  1. Uberoi R (2006). "Quality assurance guidelines for superior vena cava stenting in malignant disease". Cardiovasc Intervent Radiol. 29 (3): 319–22. doi:10.1007/s00270-005-0284-9. PMID 16502166.
  2. Superior Vena Cava Syndrome. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/managing-side-effects/superior-vena-cava-syndrome/?region=bc Accessed on January 13, 2016

Linked-in.jpg